const snpDatabase = {
  // ============================================================
  // LONGEVITY & TELOMERE (~30 SNPs)
  // ============================================================
  "rs2736100": {
    rsid: "rs2736100",
    gene: "TERT",
    chromosome: "5",
    position: 1286516,
    categories: ["longevity"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "A",
    trait: "TERT — Telomere Length",
    riskDescription: "Associated with shorter telomere length and accelerated cellular aging",
    normalDescription: "Normal telomere maintenance",
    heterozygousDescription: "Slightly reduced telomere length",
    populationFrequency: { AA: 0.25, AC: 0.5, CC: 0.25 },
    conditions: ["Shorter telomeres", "Accelerated aging"],
    recommendations: ["Consider telomere-supportive lifestyle", "Regular exercise", "Stress management"],
    references: ["PMID:19412176"]
  },
  "rs12696304": {
    rsid: "rs12696304",
    gene: "TERC",
    chromosome: "3",
    position: 169763483,
    categories: ["longevity"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "C",
    trait: "TERC — Telomerase RNA Component",
    riskDescription: "Reduced telomerase activity and shorter telomeres",
    normalDescription: "Normal telomerase RNA expression",
    heterozygousDescription: "Mildly reduced telomerase activity",
    populationFrequency: { CC: 0.35, CG: 0.47, GG: 0.18 },
    conditions: ["Telomere shortening", "Biological aging"],
    recommendations: ["Antioxidant-rich diet", "Avoid chronic stress"],
    references: ["PMID:21304973"]
  },
  "rs10936599": {
    rsid: "rs10936599",
    gene: "OBFC1",
    chromosome: "10",
    position: 105676587,
    categories: ["longevity"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "T",
    trait: "OBFC1 — Telomere Length Regulation",
    riskDescription: "Associated with shorter leukocyte telomere length",
    normalDescription: "Normal telomere length regulation",
    heterozygousDescription: "Modestly shorter telomeres",
    populationFrequency: { TT: 0.45, TC: 0.43, CC: 0.12 },
    conditions: ["Shorter telomeres", "Cardiovascular aging"],
    recommendations: ["Maintain healthy BMI", "Regular cardiovascular exercise"],
    references: ["PMID:21304973"]
  },
  "rs7726159": {
    rsid: "rs7726159",
    gene: "TERT",
    chromosome: "5",
    position: 1282414,
    categories: ["longevity"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "A",
    trait: "TERT — Telomere Maintenance",
    riskDescription: "Variant associated with altered telomere length",
    normalDescription: "Normal TERT function",
    heterozygousDescription: "Intermediate telomere effect",
    populationFrequency: { AA: 0.3, AC: 0.48, CC: 0.22 },
    conditions: ["Telomere length variation"],
    recommendations: ["Telomere-supportive nutrients (omega-3, vitamin D)"],
    references: ["PMID:23535729"]
  },
  "rs2853669": {
    rsid: "rs2853669",
    gene: "TERT",
    chromosome: "5",
    position: 1295234,
    categories: ["longevity"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "TERT Promoter — Telomerase Expression",
    riskDescription: "Reduced TERT promoter activity and lower telomerase expression",
    normalDescription: "Normal TERT promoter activity",
    heterozygousDescription: "Mildly reduced TERT expression",
    populationFrequency: { GG: 0.4, GA: 0.44, AA: 0.16 },
    conditions: ["Reduced telomerase", "Accelerated aging risk"],
    recommendations: ["Consider TA-65 or astragalus supplementation discussion with doctor"],
    references: ["PMID:22426483"]
  },
  "rs2802292": {
    rsid: "rs2802292",
    gene: "FOXO3",
    chromosome: "6",
    position: 108973560,
    categories: ["longevity"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "G",
    trait: "FOXO3 — Longevity Gene",
    riskDescription: "Common genotype without longevity advantage",
    normalDescription: "Protective allele associated with exceptional longevity",
    heterozygousDescription: "Partial longevity benefit",
    populationFrequency: { TT: 0.42, TG: 0.44, GG: 0.14 },
    conditions: ["Longevity", "Stress resistance", "Insulin sensitivity"],
    recommendations: ["Caloric restriction may amplify FOXO3 benefits", "Regular fasting"],
    references: ["PMID:18765803"]
  },
  "rs429358": {
    rsid: "rs429358",
    gene: "APOE",
    chromosome: "19",
    position: 44908684,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "T",
    trait: "APOE ε4 — Alzheimer's & Cardiovascular Risk",
    riskDescription: "APOE ε4 allele: significantly increased risk for late-onset Alzheimer's disease and cardiovascular disease",
    normalDescription: "APOE ε3 (common variant): average Alzheimer's risk",
    heterozygousDescription: "One copy of ε4: 3-4x increased Alzheimer's risk",
    populationFrequency: { TT: 0.6, TC: 0.33, CC: 0.07 },
    conditions: ["Late-onset Alzheimer's disease", "Cardiovascular disease", "Hyperlipidemia"],
    recommendations: ["Regular cognitive assessment after 50", "Mediterranean diet", "Cardiovascular exercise", "DHA supplementation"],
    references: ["PMID:8346443", "PMID:19734902"]
  },
  "rs7412": {
    rsid: "rs7412",
    gene: "APOE",
    chromosome: "19",
    position: 44908822,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "APOE ε2 — Protective Longevity Variant",
    riskDescription: "APOE ε2 is generally protective; rare homozygosity may affect lipid metabolism",
    normalDescription: "Standard APOE ε3 allele",
    heterozygousDescription: "One ε2 copy: reduced Alzheimer's risk",
    populationFrequency: { CC: 0.77, CT: 0.21, TT: 0.02 },
    conditions: ["Reduced Alzheimer's risk (protective)", "Type III hyperlipoproteinemia (rare, homozygous)"],
    recommendations: ["Generally protective variant", "Monitor lipid panel if homozygous"],
    references: ["PMID:8346443"]
  },
  "rs5882": {
    rsid: "rs5882",
    gene: "CETP",
    chromosome: "16",
    position: 56995236,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "A",
    trait: "CETP — HDL Cholesterol & Longevity",
    riskDescription: "Lower CETP activity, associated with higher HDL and longevity",
    normalDescription: "Normal CETP activity",
    heterozygousDescription: "Intermediate HDL levels",
    populationFrequency: { AA: 0.4, AG: 0.45, GG: 0.15 },
    conditions: ["HDL cholesterol levels", "Cardiovascular longevity"],
    recommendations: ["Monitor lipid panel", "Heart-healthy diet"],
    references: ["PMID:12586883"]
  },
  "rs1800795": {
    rsid: "rs1800795",
    gene: "IL6",
    chromosome: "7",
    position: 22766645,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "G",
    trait: "IL-6 — Inflammatory Aging",
    riskDescription: "Higher IL-6 production, increased systemic inflammation",
    normalDescription: "Lower baseline inflammation",
    heterozygousDescription: "Moderate inflammatory response",
    populationFrequency: { GG: 0.25, GC: 0.5, CC: 0.25 },
    conditions: ["Chronic inflammation", "Inflammaging", "Cardiovascular disease risk"],
    recommendations: ["Anti-inflammatory diet (omega-3, turmeric)", "Regular exercise", "Adequate sleep"],
    references: ["PMID:9855620"]
  },
  "rs1042522": {
    rsid: "rs1042522",
    gene: "TP53",
    chromosome: "17",
    position: 7676154,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "G",
    trait: "TP53 — Tumor Suppressor & Aging",
    riskDescription: "Pro72 variant: better DNA repair but potentially accelerated aging",
    normalDescription: "Arg72 variant: enhanced apoptosis",
    heterozygousDescription: "Heterozygous — balanced repair/apoptosis",
    populationFrequency: { GG: 0.4, GC: 0.45, CC: 0.15 },
    conditions: ["Cancer susceptibility variation", "Aging rate"],
    recommendations: ["Regular cancer screening", "Antioxidant-rich diet"],
    references: ["PMID:12474143"]
  },
  "rs3758391": {
    rsid: "rs3758391",
    gene: "SIRT1",
    chromosome: "10",
    position: 69644427,
    categories: ["longevity"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "T",
    trait: "SIRT1 — Sirtuin Longevity Pathway",
    riskDescription: "Reduced SIRT1 expression affecting cellular stress response",
    normalDescription: "Normal sirtuin activity supporting longevity",
    heterozygousDescription: "Intermediate SIRT1 expression",
    populationFrequency: { TT: 0.55, TC: 0.38, CC: 0.07 },
    conditions: ["Cellular aging", "Metabolic regulation"],
    recommendations: ["Resveratrol-rich foods", "Intermittent fasting", "NAD+ precursors (NMN/NR)"],
    references: ["PMID:22882745"]
  },
  "rs1801282": {
    rsid: "rs1801282",
    gene: "PPARG",
    chromosome: "3",
    position: 12393125,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "G",
    trait: "PPARγ Pro12Ala — Insulin Sensitivity",
    riskDescription: "Pro/Pro genotype: higher type 2 diabetes risk",
    normalDescription: "Ala variant: improved insulin sensitivity",
    heterozygousDescription: "Intermediate insulin sensitivity",
    populationFrequency: { CC: 0.75, CG: 0.23, GG: 0.02 },
    conditions: ["Type 2 diabetes risk", "Insulin resistance"],
    recommendations: ["Regular blood glucose monitoring", "Low glycemic diet", "Exercise"],
    references: ["PMID:11101840"]
  },
  "rs1799752": {
    rsid: "rs1799752",
    gene: "ACE",
    chromosome: "17",
    position: 63488529,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "D",
    normalAllele: "I",
    trait: "ACE I/D — Cardiovascular & Longevity",
    riskDescription: "DD genotype: higher ACE levels, cardiovascular risk",
    normalDescription: "II genotype: endurance advantage, lower ACE",
    heterozygousDescription: "Intermediate ACE levels",
    populationFrequency: { II: 0.25, ID: 0.5, DD: 0.25 },
    conditions: ["Hypertension risk", "Cardiovascular disease", "Exercise response"],
    recommendations: ["Blood pressure monitoring", "ACE inhibitor response awareness"],
    references: ["PMID:1328889"]
  },
  "rs2069762": {
    rsid: "rs2069762",
    gene: "IL2",
    chromosome: "4",
    position: 123377980,
    categories: ["longevity"],
    significance: "moderate",
    riskAllele: "G",
    normalAllele: "T",
    trait: "IL-2 — Immune Function & Longevity",
    riskDescription: "Altered IL-2 production affecting immune aging",
    normalDescription: "Normal IL-2 immune signaling",
    heterozygousDescription: "Intermediate IL-2 levels",
    populationFrequency: { TT: 0.45, TG: 0.42, GG: 0.13 },
    conditions: ["Immune aging", "Autoimmune susceptibility"],
    recommendations: ["Support immune health", "Adequate zinc and vitamin C"],
    references: ["PMID:16249881"]
  },
  "rs1800629": {
    rsid: "rs1800629",
    gene: "TNF",
    chromosome: "6",
    position: 31575254,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "TNF-α — Inflammatory Cytokine",
    riskDescription: "Higher TNF-α production, increased chronic inflammation",
    normalDescription: "Normal TNF-α levels",
    heterozygousDescription: "Mildly elevated TNF-α",
    populationFrequency: { GG: 0.7, GA: 0.27, AA: 0.03 },
    conditions: ["Chronic inflammation", "Autoimmune disease risk", "Sepsis susceptibility"],
    recommendations: ["Anti-inflammatory lifestyle", "Omega-3 fatty acids", "Curcumin"],
    references: ["PMID:8833554"]
  },
  "rs4880": {
    rsid: "rs4880",
    gene: "SOD2",
    chromosome: "6",
    position: 159692840,
    categories: ["longevity"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "SOD2 Ala16Val — Oxidative Stress Defense",
    riskDescription: "Reduced mitochondrial antioxidant defense",
    normalDescription: "Efficient mitochondrial superoxide dismutase",
    heterozygousDescription: "Intermediate antioxidant capacity",
    populationFrequency: { CC: 0.25, CT: 0.5, TT: 0.25 },
    conditions: ["Oxidative stress", "Mitochondrial aging", "Cancer risk variation"],
    recommendations: ["Antioxidant supplementation (CoQ10, vitamin C)", "Avoid excessive iron intake"],
    references: ["PMID:10072423"]
  },
  "rs1799983": {
    rsid: "rs1799983",
    gene: "NOS3",
    chromosome: "7",
    position: 150999023,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "G",
    trait: "eNOS — Nitric Oxide & Vascular Health",
    riskDescription: "Reduced nitric oxide production, impaired vascular function",
    normalDescription: "Normal endothelial nitric oxide production",
    heterozygousDescription: "Mildly reduced NO production",
    populationFrequency: { GG: 0.42, GT: 0.44, TT: 0.14 },
    conditions: ["Endothelial dysfunction", "Hypertension", "Cardiovascular disease"],
    recommendations: ["Beet root juice (nitrates)", "L-arginine", "Regular exercise"],
    references: ["PMID:9462492"]
  },
  "rs1800497": {
    rsid: "rs1800497",
    gene: "ANKK1/DRD2",
    chromosome: "11",
    position: 113400106,
    categories: ["longevity", "traits"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "DRD2/ANKK1 Taq1A — Dopamine Receptor",
    riskDescription: "Reduced dopamine D2 receptor density",
    normalDescription: "Normal dopamine receptor density",
    heterozygousDescription: "Mildly reduced D2 receptor availability",
    populationFrequency: { CC: 0.5, CT: 0.4, TT: 0.1 },
    conditions: ["Reward sensitivity", "Addiction susceptibility", "Cognitive function"],
    recommendations: ["Mindfulness practice", "Regular dopamine-boosting activities (exercise)"],
    references: ["PMID:2234697"]
  },
  "rs6265": {
    rsid: "rs6265",
    gene: "BDNF",
    chromosome: "11",
    position: 27679916,
    categories: ["longevity", "health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "BDNF Val66Met — Brain-Derived Neurotrophic Factor",
    riskDescription: "Reduced BDNF secretion, affecting neuroplasticity and memory",
    normalDescription: "Normal BDNF function supporting brain health",
    heterozygousDescription: "Mildly reduced activity-dependent BDNF secretion",
    populationFrequency: { CC: 0.62, CT: 0.33, TT: 0.05 },
    conditions: ["Memory and learning variation", "Depression susceptibility", "Anxiety"],
    recommendations: ["Regular aerobic exercise (boosts BDNF)", "Meditation", "Lion's mane mushroom"],
    references: ["PMID:14573789"]
  },
  // ============================================================
  // HEALTH RISKS (~50 SNPs)
  // ============================================================
  "rs80357906": {
    rsid: "rs80357906",
    gene: "BRCA1",
    chromosome: "17",
    position: 43093449,
    categories: ["health"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "BRCA1 5382insC — Breast & Ovarian Cancer",
    riskDescription: "Pathogenic BRCA1 variant: significantly elevated breast and ovarian cancer risk",
    normalDescription: "No pathogenic BRCA1 variant detected",
    heterozygousDescription: "Carrier: 60-80% lifetime breast cancer risk",
    populationFrequency: { CC: 0.998, CT: 2e-3, TT: 0 },
    conditions: ["Hereditary breast cancer", "Ovarian cancer", "Prostate cancer risk"],
    recommendations: ["Genetic counseling strongly recommended", "Enhanced screening", "Discuss prophylactic options"],
    references: ["PMID:8524414"]
  },
  "rs28897696": {
    rsid: "rs28897696",
    gene: "BRCA2",
    chromosome: "13",
    position: 32929387,
    categories: ["health"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "BRCA2 — Breast Cancer Susceptibility",
    riskDescription: "Pathogenic BRCA2 variant associated with increased cancer risk",
    normalDescription: "No pathogenic BRCA2 variant",
    heterozygousDescription: "Carrier: elevated breast and pancreatic cancer risk",
    populationFrequency: { CC: 0.999, CT: 1e-3, TT: 0 },
    conditions: ["Hereditary breast cancer", "Pancreatic cancer", "Male breast cancer"],
    recommendations: ["Genetic counseling", "Regular screening", "Family cascade testing"],
    references: ["PMID:20104584"]
  },
  "rs1333049": {
    rsid: "rs1333049",
    gene: "9p21.3",
    chromosome: "9",
    position: 22125503,
    categories: ["health"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "G",
    trait: "9p21 — Coronary Artery Disease",
    riskDescription: "Significantly increased risk of coronary artery disease and myocardial infarction",
    normalDescription: "Average cardiovascular risk at this locus",
    heterozygousDescription: "Moderately increased CAD risk (~1.3x)",
    populationFrequency: { GG: 0.25, GC: 0.5, CC: 0.25 },
    conditions: ["Coronary artery disease", "Myocardial infarction", "Atherosclerosis"],
    recommendations: ["Regular cardiovascular screening", "Lipid panel monitoring", "Heart-healthy diet"],
    references: ["PMID:17478679"]
  },
  "rs10757278": {
    rsid: "rs10757278",
    gene: "9p21.3",
    chromosome: "9",
    position: 22124477,
    categories: ["health"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "A",
    trait: "9p21 — Coronary Heart Disease",
    riskDescription: "Increased risk of coronary heart disease",
    normalDescription: "Lower cardiovascular risk at this locus",
    heterozygousDescription: "Intermediate cardiovascular risk",
    populationFrequency: { AA: 0.28, AG: 0.49, GG: 0.23 },
    conditions: ["Coronary artery disease", "Aortic aneurysm"],
    recommendations: ["Cardiovascular risk management", "Regular exercise"],
    references: ["PMID:17478681"]
  },
  "rs4977574": {
    rsid: "rs4977574",
    gene: "CDKN2B-AS1",
    chromosome: "9",
    position: 22098619,
    categories: ["health"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "A",
    trait: "CDKN2B-AS1 — Cardiovascular Disease",
    riskDescription: "Associated with increased coronary heart disease risk",
    normalDescription: "Average cardiovascular risk",
    heterozygousDescription: "Mildly elevated CHD risk",
    populationFrequency: { AA: 0.26, AG: 0.49, GG: 0.25 },
    conditions: ["Coronary heart disease", "Type 2 diabetes"],
    recommendations: ["Heart-healthy lifestyle", "Regular check-ups"],
    references: ["PMID:17478679"]
  },
  "rs7903146": {
    rsid: "rs7903146",
    gene: "TCF7L2",
    chromosome: "10",
    position: 114758349,
    categories: ["health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "TCF7L2 — Type 2 Diabetes",
    riskDescription: "Strongest common genetic risk factor for type 2 diabetes (1.4x per allele)",
    normalDescription: "Average type 2 diabetes risk at this locus",
    heterozygousDescription: "Moderately increased T2D risk (~1.4x)",
    populationFrequency: { CC: 0.49, CT: 0.42, TT: 0.09 },
    conditions: ["Type 2 diabetes", "Impaired insulin secretion", "Gestational diabetes"],
    recommendations: ["Regular glucose monitoring", "Low glycemic index diet", "Weight management", "Regular exercise"],
    references: ["PMID:16415884"]
  },
  "rs2187668": {
    rsid: "rs2187668",
    gene: "HLA-DQA1",
    chromosome: "6",
    position: 32605884,
    categories: ["health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "HLA-DQ2.5 — Celiac Disease",
    riskDescription: "HLA-DQ2.5 haplotype: major genetic risk factor for celiac disease",
    normalDescription: "Absence of primary celiac risk haplotype",
    heterozygousDescription: "Carrier of HLA-DQ2.5: elevated celiac risk",
    populationFrequency: { CC: 0.72, CT: 0.25, TT: 0.03 },
    conditions: ["Celiac disease", "Gluten sensitivity", "Dermatitis herpetiformis"],
    recommendations: ["Consider celiac antibody testing if symptomatic", "Gluten-free diet if diagnosed"],
    references: ["PMID:18311140"]
  },
  "rs12255372": {
    rsid: "rs12255372",
    gene: "TCF7L2",
    chromosome: "10",
    position: 114808902,
    categories: ["health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "G",
    trait: "TCF7L2 — Type 2 Diabetes Risk",
    riskDescription: "Increased type 2 diabetes risk through impaired beta-cell function",
    normalDescription: "Normal beta-cell function at this locus",
    heterozygousDescription: "Moderately increased T2D risk",
    populationFrequency: { GG: 0.53, GT: 0.4, TT: 0.07 },
    conditions: ["Type 2 diabetes", "Beta-cell dysfunction"],
    recommendations: ["Blood glucose monitoring", "Healthy diet and exercise"],
    references: ["PMID:16415884"]
  },
  "rs1801280": {
    rsid: "rs1801280",
    gene: "NAT2",
    chromosome: "8",
    position: 18257854,
    categories: ["health", "pharma"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "NAT2 — Drug Acetylation Speed",
    riskDescription: "Slow acetylator: altered drug metabolism, increased drug toxicity risk",
    normalDescription: "Rapid acetylator: normal drug metabolism",
    heterozygousDescription: "Intermediate acetylator status",
    populationFrequency: { GG: 0.3, GA: 0.48, AA: 0.22 },
    conditions: ["Drug metabolism variation", "Isoniazid toxicity risk", "Bladder cancer risk (occupational)"],
    recommendations: ["Inform physician of acetylator status", "Dose adjustments for certain drugs"],
    references: ["PMID:8807664"]
  },
  "rs6025": {
    rsid: "rs6025",
    gene: "F5",
    chromosome: "1",
    position: 169519049,
    categories: ["health"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "Factor V Leiden — Blood Clotting",
    riskDescription: "Factor V Leiden mutation: 3-8x increased risk of venous thromboembolism",
    normalDescription: "Normal Factor V function",
    heterozygousDescription: "Heterozygous carrier: 3-5x VTE risk",
    populationFrequency: { CC: 0.95, CT: 0.047, TT: 3e-3 },
    conditions: ["Deep vein thrombosis", "Pulmonary embolism", "Pregnancy complications"],
    recommendations: ["Avoid prolonged immobility", "Discuss with doctor before hormonal contraceptives", "Compression stockings for travel"],
    references: ["PMID:7989264"]
  },
  "rs1799963": {
    rsid: "rs1799963",
    gene: "F2",
    chromosome: "11",
    position: 46761055,
    categories: ["health"],
    significance: "pathogenic",
    riskAllele: "A",
    normalAllele: "G",
    trait: "Prothrombin G20210A — Thrombophilia",
    riskDescription: "Elevated prothrombin levels, 2-5x increased VTE risk",
    normalDescription: "Normal prothrombin levels",
    heterozygousDescription: "Carrier: 2-3x VTE risk",
    populationFrequency: { GG: 0.97, GA: 0.029, AA: 1e-3 },
    conditions: ["Venous thromboembolism", "Stroke risk", "Pregnancy loss"],
    recommendations: ["Thrombophilia awareness", "Discuss anticoagulation in high-risk situations"],
    references: ["PMID:8844239"]
  },
  "rs1800896": {
    rsid: "rs1800896",
    gene: "IL10",
    chromosome: "1",
    position: 206773552,
    categories: ["health"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "IL-10 — Anti-inflammatory Cytokine",
    riskDescription: "Lower IL-10 production, reduced anti-inflammatory capacity",
    normalDescription: "Higher IL-10 production, better anti-inflammatory response",
    heterozygousDescription: "Intermediate IL-10 production",
    populationFrequency: { GG: 0.25, GA: 0.5, AA: 0.25 },
    conditions: ["Inflammatory bowel disease", "Rheumatoid arthritis", "Transplant rejection"],
    recommendations: ["Anti-inflammatory diet", "Probiotics for gut health"],
    references: ["PMID:9399958"]
  },
  "rs1805010": {
    rsid: "rs1805010",
    gene: "IL4R",
    chromosome: "16",
    position: 27363019,
    categories: ["health"],
    significance: "moderate",
    riskAllele: "A",
    normalAllele: "G",
    trait: "IL-4Rα — Allergy & Asthma Susceptibility",
    riskDescription: "Increased susceptibility to allergic diseases and asthma",
    normalDescription: "Normal IL-4 receptor signaling",
    heterozygousDescription: "Moderately increased allergy risk",
    populationFrequency: { GG: 0.3, GA: 0.49, AA: 0.21 },
    conditions: ["Asthma", "Allergic rhinitis", "Atopic dermatitis"],
    recommendations: ["Allergen avoidance", "Consider allergy testing"],
    references: ["PMID:10471617"]
  },
  "rs2228145": {
    rsid: "rs2228145",
    gene: "IL6R",
    chromosome: "1",
    position: 154426970,
    categories: ["health"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "A",
    trait: "IL-6R Asp358Ala — Inflammation",
    riskDescription: "Altered IL-6 signaling, cardiovascular implications",
    normalDescription: "Normal IL-6 receptor function",
    heterozygousDescription: "Intermediate IL-6R signaling",
    populationFrequency: { AA: 0.4, AC: 0.45, CC: 0.15 },
    conditions: ["Coronary heart disease", "Rheumatoid arthritis", "Systemic inflammation"],
    recommendations: ["Monitor inflammatory markers (CRP)", "Anti-inflammatory lifestyle"],
    references: ["PMID:22158537"]
  },
  "rs1048943": {
    rsid: "rs1048943",
    gene: "CYP1A1",
    chromosome: "15",
    position: 75011882,
    categories: ["health"],
    significance: "moderate",
    riskAllele: "G",
    normalAllele: "A",
    trait: "CYP1A1 — Xenobiotic Metabolism",
    riskDescription: "Increased activation of pro-carcinogens from tobacco smoke and environmental pollutants",
    normalDescription: "Normal xenobiotic metabolism",
    heterozygousDescription: "Moderately increased carcinogen activation",
    populationFrequency: { AA: 0.82, AG: 0.17, GG: 0.01 },
    conditions: ["Lung cancer risk (smokers)", "Environmental toxin sensitivity"],
    recommendations: ["Avoid tobacco smoke", "Cruciferous vegetables (broccoli, kale)"],
    references: ["PMID:2183157"]
  },
  "rs4986893": {
    rsid: "rs4986893",
    gene: "CYP2C19",
    chromosome: "10",
    position: 96540410,
    categories: ["health", "pharma"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "CYP2C19*3 — Drug Metabolism",
    riskDescription: "Poor metabolizer of CYP2C19 substrates including clopidogrel",
    normalDescription: "Normal CYP2C19 metabolism",
    heterozygousDescription: "Intermediate metabolizer",
    populationFrequency: { GG: 0.94, GA: 0.06, AA: 2e-3 },
    conditions: ["Clopidogrel resistance", "Proton pump inhibitor sensitivity"],
    recommendations: ["Pharmacogenomic-guided prescribing", "Alternative antiplatelet agents"],
    references: ["PMID:18781855"]
  },
  "rs11614913": {
    rsid: "rs11614913",
    gene: "MIR196A2",
    chromosome: "12",
    position: 54385599,
    categories: ["health"],
    significance: "moderate",
    riskAllele: "C",
    normalAllele: "T",
    trait: "miR-196a2 — Cancer Susceptibility",
    riskDescription: "Altered microRNA processing, associated with multiple cancer types",
    normalDescription: "Normal miR-196a2 expression",
    heterozygousDescription: "Moderately altered miRNA expression",
    populationFrequency: { TT: 0.3, TC: 0.48, CC: 0.22 },
    conditions: ["Breast cancer risk", "Lung cancer risk", "Gastric cancer risk"],
    recommendations: ["Regular cancer screening", "Healthy lifestyle"],
    references: ["PMID:18250568"]
  },
  "rs1695": {
    rsid: "rs1695",
    gene: "GSTP1",
    chromosome: "11",
    position: 67585218,
    categories: ["health"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "A",
    trait: "GSTP1 — Detoxification Enzyme",
    riskDescription: "Reduced glutathione S-transferase activity, impaired detoxification",
    normalDescription: "Normal detoxification capacity",
    heterozygousDescription: "Mildly reduced detoxification",
    populationFrequency: { AA: 0.42, AG: 0.45, GG: 0.13 },
    conditions: ["Reduced xenobiotic detoxification", "Cancer susceptibility", "Chemotherapy response"],
    recommendations: ["Cruciferous vegetables", "Adequate glutathione precursors (NAC)"],
    references: ["PMID:10702241"]
  },
  "rs1229984": {
    rsid: "rs1229984",
    gene: "ADH1B",
    chromosome: "4",
    position: 99318162,
    categories: ["health", "nutrition"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "ADH1B — Alcohol Metabolism",
    riskDescription: "Rapid alcohol to acetaldehyde conversion — protective against alcoholism but causes flushing",
    normalDescription: "Standard alcohol metabolism rate",
    heterozygousDescription: "Faster alcohol metabolism",
    populationFrequency: { CC: 0.7, CT: 0.26, TT: 0.04 },
    conditions: ["Alcohol flush reaction", "Reduced alcoholism risk", "Esophageal cancer risk with alcohol"],
    recommendations: ["Limit alcohol consumption", "Awareness of flush reaction"],
    references: ["PMID:18385739"]
  },
  // ============================================================
  // PHARMACOGENOMICS (~40 SNPs)
  // ============================================================
  "rs3892097": {
    rsid: "rs3892097",
    gene: "CYP2D6",
    chromosome: "22",
    position: 42524947,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "CYP2D6*4 — Drug Metabolism",
    riskDescription: "Non-functional CYP2D6 allele: poor metabolizer of codeine, tamoxifen, many antidepressants",
    normalDescription: "Normal CYP2D6 metabolism",
    heterozygousDescription: "Intermediate metabolizer: reduced drug activation",
    populationFrequency: { GG: 0.56, GA: 0.37, AA: 0.07 },
    conditions: ["Poor drug metabolism", "Codeine non-response", "Tamoxifen reduced efficacy"],
    recommendations: ["Pharmacogenomic card for healthcare providers", "Alternative pain medications to codeine", "Tamoxifen alternatives if applicable"],
    references: ["PMID:15625273"]
  },
  "rs1065852": {
    rsid: "rs1065852",
    gene: "CYP2D6",
    chromosome: "22",
    position: 42526694,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "CYP2D6*10 — Reduced Drug Metabolism",
    riskDescription: "Reduced CYP2D6 activity affecting metabolism of many medications",
    normalDescription: "Normal CYP2D6 function",
    heterozygousDescription: "Intermediate metabolizer",
    populationFrequency: { GG: 0.5, GA: 0.4, AA: 0.1 },
    conditions: ["Reduced drug metabolism", "Increased drug sensitivity"],
    recommendations: ["Dose adjustments may be needed", "Inform prescribers"],
    references: ["PMID:19512959"]
  },
  "rs4244285": {
    rsid: "rs4244285",
    gene: "CYP2C19",
    chromosome: "10",
    position: 96541616,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "CYP2C19*2 — Clopidogrel Response",
    riskDescription: "Poor CYP2C19 metabolizer: clopidogrel (Plavix) may be ineffective",
    normalDescription: "Normal clopidogrel activation",
    heterozygousDescription: "Intermediate metabolizer: reduced clopidogrel efficacy",
    populationFrequency: { GG: 0.6, GA: 0.34, AA: 0.06 },
    conditions: ["Clopidogrel resistance", "PPI altered metabolism", "Antidepressant dose sensitivity"],
    recommendations: ["FDA boxed warning on clopidogrel", "Consider prasugrel or ticagrelor alternatives", "PPI dose adjustment"],
    references: ["PMID:19706858"]
  },
  "rs12248560": {
    rsid: "rs12248560",
    gene: "CYP2C19",
    chromosome: "10",
    position: 96522463,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "CYP2C19*17 — Ultra-Rapid Metabolism",
    riskDescription: "Ultra-rapid CYP2C19 metabolizer: faster drug processing, may need higher doses",
    normalDescription: "Normal CYP2C19 metabolism speed",
    heterozygousDescription: "Rapid metabolizer: somewhat faster drug processing",
    populationFrequency: { CC: 0.55, CT: 0.38, TT: 0.07 },
    conditions: ["Ultra-rapid drug metabolism", "Possible therapeutic failure at standard doses"],
    recommendations: ["May need dose increases for clopidogrel, PPIs, some antidepressants"],
    references: ["PMID:16958828"]
  },
  "rs762551": {
    rsid: "rs762551",
    gene: "CYP1A2",
    chromosome: "15",
    position: 75041917,
    categories: ["pharma", "nutrition"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "A",
    trait: "CYP1A2 — Caffeine Metabolism",
    riskDescription: "Slow caffeine metabolizer: caffeine stays in system longer, increased cardiovascular risk with high coffee intake",
    normalDescription: "Fast caffeine metabolizer: rapid caffeine clearance",
    heterozygousDescription: "Intermediate caffeine metabolism",
    populationFrequency: { AA: 0.46, AC: 0.44, CC: 0.1 },
    conditions: ["Slow caffeine metabolism", "Insomnia from caffeine", "Heart attack risk with >3 cups coffee/day"],
    recommendations: ["Limit caffeine to 1-2 cups/day if slow metabolizer", "No caffeine after noon", "Switch to decaf or tea"],
    references: ["PMID:16522833"]
  },
  "rs9923231": {
    rsid: "rs9923231",
    gene: "VKORC1",
    chromosome: "16",
    position: 31096368,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "VKORC1 — Warfarin Sensitivity",
    riskDescription: "Increased warfarin sensitivity: requires significantly lower doses",
    normalDescription: "Standard warfarin dose requirements",
    heterozygousDescription: "Intermediate warfarin sensitivity: moderate dose reduction",
    populationFrequency: { CC: 0.37, CT: 0.47, TT: 0.16 },
    conditions: ["Warfarin dose sensitivity", "Bleeding risk with standard doses"],
    recommendations: ["FDA-recommended pharmacogenomic dosing for warfarin", "Start with lower doses", "More frequent INR monitoring"],
    references: ["PMID:15930419"]
  },
  "rs4149056": {
    rsid: "rs4149056",
    gene: "SLCO1B1",
    chromosome: "12",
    position: 21331549,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "T",
    trait: "SLCO1B1 — Statin Myopathy Risk",
    riskDescription: "Increased risk of statin-induced myopathy (muscle pain/damage), especially with simvastatin",
    normalDescription: "Normal statin tolerance",
    heterozygousDescription: "Moderately increased myopathy risk (~4.5x with simvastatin)",
    populationFrequency: { TT: 0.73, TC: 0.25, CC: 0.02 },
    conditions: ["Statin-induced myopathy", "Rhabdomyolysis risk", "Simvastatin intolerance"],
    recommendations: ["Avoid high-dose simvastatin", "Consider rosuvastatin or pravastatin", "Monitor CK levels"],
    references: ["PMID:18650507"]
  },
  "rs1057910": {
    rsid: "rs1057910",
    gene: "CYP2C9",
    chromosome: "10",
    position: 96702047,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "A",
    trait: "CYP2C9*3 — Drug Metabolism",
    riskDescription: "Significantly reduced CYP2C9 activity: affects warfarin, NSAIDs, phenytoin metabolism",
    normalDescription: "Normal CYP2C9 metabolism",
    heterozygousDescription: "Intermediate metabolizer: reduced clearance of CYP2C9 substrates",
    populationFrequency: { AA: 0.85, AC: 0.14, CC: 0.01 },
    conditions: ["Warfarin sensitivity", "NSAID toxicity risk", "Phenytoin toxicity risk"],
    recommendations: ["Reduced warfarin doses needed", "NSAID caution", "Therapeutic drug monitoring"],
    references: ["PMID:10208644"]
  },
  "rs1799853": {
    rsid: "rs1799853",
    gene: "CYP2C9",
    chromosome: "10",
    position: 96698440,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "CYP2C9*2 — Warfarin & NSAID Metabolism",
    riskDescription: "Reduced CYP2C9 activity affecting warfarin and NSAID processing",
    normalDescription: "Normal CYP2C9*1 function",
    heterozygousDescription: "Intermediate metabolizer",
    populationFrequency: { CC: 0.78, CT: 0.2, TT: 0.02 },
    conditions: ["Warfarin dose sensitivity", "NSAID adverse effects"],
    recommendations: ["Lower warfarin starting dose", "Monitor for NSAID side effects"],
    references: ["PMID:10208644"]
  },
  "rs4148323": {
    rsid: "rs4148323",
    gene: "UGT1A1",
    chromosome: "2",
    position: 234669144,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "UGT1A1*6 — Irinotecan Toxicity",
    riskDescription: "Reduced UGT1A1 activity: increased risk of irinotecan toxicity",
    normalDescription: "Normal bilirubin conjugation and drug metabolism",
    heterozygousDescription: "Intermediate UGT1A1 activity",
    populationFrequency: { GG: 0.8, GA: 0.18, AA: 0.02 },
    conditions: ["Irinotecan toxicity", "Gilbert syndrome", "Hyperbilirubinemia"],
    recommendations: ["Irinotecan dose reduction if applicable", "Monitor bilirubin levels"],
    references: ["PMID:17510684"]
  },
  "rs28399504": {
    rsid: "rs28399504",
    gene: "CYP2C19",
    chromosome: "10",
    position: 96522613,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "A",
    trait: "CYP2C19*4 — Drug Metabolism Variant",
    riskDescription: "Non-functional CYP2C19 allele",
    normalDescription: "Normal CYP2C19 function",
    heterozygousDescription: "Intermediate metabolizer",
    populationFrequency: { AA: 0.995, AG: 5e-3, GG: 0 },
    conditions: ["Poor CYP2C19 metabolism"],
    recommendations: ["Consider alternative medications to CYP2C19 substrates"],
    references: ["PMID:14657094"]
  },
  "rs1128503": {
    rsid: "rs1128503",
    gene: "ABCB1",
    chromosome: "7",
    position: 87550285,
    categories: ["pharma"],
    significance: "moderate",
    riskAllele: "T",
    normalAllele: "C",
    trait: "ABCB1/MDR1 — Drug Transport",
    riskDescription: "Altered P-glycoprotein expression affecting drug absorption and distribution",
    normalDescription: "Normal drug transport",
    heterozygousDescription: "Intermediate drug transport efficiency",
    populationFrequency: { CC: 0.32, CT: 0.48, TT: 0.2 },
    conditions: ["Altered drug bioavailability", "Digoxin sensitivity", "Immunosuppressant levels"],
    recommendations: ["Therapeutic drug monitoring for P-gp substrates"],
    references: ["PMID:10858656"]
  },
  "rs2032582": {
    rsid: "rs2032582",
    gene: "ABCB1",
    chromosome: "7",
    position: 87531302,
    categories: ["pharma"],
    significance: "moderate",
    riskAllele: "T",
    normalAllele: "G",
    trait: "ABCB1 Ser893Ala — Drug Efflux",
    riskDescription: "Modified P-glycoprotein function affecting multiple drug classes",
    normalDescription: "Normal P-glycoprotein efflux activity",
    heterozygousDescription: "Intermediate P-gp function",
    populationFrequency: { GG: 0.3, GT: 0.5, TT: 0.2 },
    conditions: ["Drug disposition variation", "Cancer drug resistance"],
    recommendations: ["Consider in polypharmacy situations"],
    references: ["PMID:11305860"]
  },
  "rs1045642": {
    rsid: "rs1045642",
    gene: "ABCB1",
    chromosome: "7",
    position: 87509329,
    categories: ["pharma"],
    significance: "moderate",
    riskAllele: "T",
    normalAllele: "C",
    trait: "ABCB1 C3435T — Drug Absorption",
    riskDescription: "Reduced P-glycoprotein expression, altered drug levels",
    normalDescription: "Normal P-glycoprotein expression",
    heterozygousDescription: "Intermediate expression levels",
    populationFrequency: { CC: 0.26, CT: 0.5, TT: 0.24 },
    conditions: ["Increased digoxin levels", "Cyclosporine sensitivity", "HIV protease inhibitor levels"],
    recommendations: ["Drug level monitoring when relevant"],
    references: ["PMID:10858656"]
  },
  "rs4633": {
    rsid: "rs4633",
    gene: "COMT",
    chromosome: "22",
    position: 19950235,
    categories: ["pharma", "traits"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "COMT — Catechol Metabolism",
    riskDescription: "Lower COMT activity, slower dopamine/catecholamine breakdown",
    normalDescription: "Normal COMT activity, efficient catecholamine clearance",
    heterozygousDescription: "Intermediate COMT activity",
    populationFrequency: { CC: 0.25, CT: 0.5, TT: 0.25 },
    conditions: ["Pain sensitivity variation", "Stress response", "Estrogen metabolism"],
    recommendations: ["Stress management techniques", "Magnesium supplementation"],
    references: ["PMID:15514402"]
  },
  "rs4680": {
    rsid: "rs4680",
    gene: "COMT",
    chromosome: "22",
    position: 19963748,
    categories: ["pharma", "traits"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "COMT Val158Met — Warrior vs Worrier",
    riskDescription: "Met/Met (Worrier): higher prefrontal dopamine, better cognition under low stress but anxious under high stress",
    normalDescription: "Val/Val (Warrior): lower prefrontal dopamine, stress-resilient but lower baseline cognition",
    heterozygousDescription: "Val/Met: balanced dopamine metabolism",
    populationFrequency: { GG: 0.25, GA: 0.5, AA: 0.25 },
    conditions: ["Stress resilience variation", "Pain sensitivity", "Cognitive style"],
    recommendations: ["Adapt stress management to genotype", "Mindfulness for Met carriers"],
    references: ["PMID:15514402"]
  },
  "rs9332131": {
    rsid: "rs9332131",
    gene: "CYP2C9",
    chromosome: "10",
    position: 96709038,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "CYP2C9*6 — Drug Metabolism",
    riskDescription: "Non-functional CYP2C9 allele affecting warfarin and NSAID metabolism",
    normalDescription: "Normal CYP2C9 function",
    heterozygousDescription: "Intermediate metabolizer",
    populationFrequency: { GG: 0.99, GA: 0.01, AA: 0 },
    conditions: ["Warfarin hypersensitivity", "NSAID toxicity"],
    recommendations: ["Significant warfarin dose reduction", "NSAID alternatives"],
    references: ["PMID:15625273"]
  },
  "rs3745274": {
    rsid: "rs3745274",
    gene: "CYP2B6",
    chromosome: "19",
    position: 41512841,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "G",
    trait: "CYP2B6*6 — Efavirenz Metabolism",
    riskDescription: "Reduced CYP2B6 activity: elevated efavirenz levels, CNS side effects",
    normalDescription: "Normal CYP2B6 metabolism",
    heterozygousDescription: "Intermediate metabolizer",
    populationFrequency: { GG: 0.55, GT: 0.38, TT: 0.07 },
    conditions: ["Efavirenz toxicity", "Cyclophosphamide metabolism", "Bupropion levels"],
    recommendations: ["Efavirenz dose adjustment", "Monitor for CNS side effects"],
    references: ["PMID:15625273"]
  },
  "rs28371725": {
    rsid: "rs28371725",
    gene: "CYP2D6",
    chromosome: "22",
    position: 42524435,
    categories: ["pharma"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "CYP2D6*41 — Reduced Drug Metabolism",
    riskDescription: "Decreased CYP2D6 function, intermediate metabolizer",
    normalDescription: "Normal CYP2D6 activity",
    heterozygousDescription: "Slightly reduced metabolism",
    populationFrequency: { CC: 0.9, CT: 0.09, TT: 0.01 },
    conditions: ["Reduced metabolism of CYP2D6 substrates"],
    recommendations: ["Consider dose adjustments for CYP2D6-metabolized drugs"],
    references: ["PMID:16958828"]
  },
  // ============================================================
  // NUTRIGENOMICS (~40 SNPs)
  // ============================================================
  "rs1801133": {
    rsid: "rs1801133",
    gene: "MTHFR",
    chromosome: "1",
    position: 11856378,
    categories: ["nutrition", "health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "MTHFR C677T — Methylation",
    riskDescription: "Reduced MTHFR enzyme activity affecting folate metabolism (~30% activity when homozygous)",
    normalDescription: "Normal MTHFR enzyme activity",
    heterozygousDescription: "Mildly reduced MTHFR activity (~65% normal)",
    populationFrequency: { CC: 0.44, CT: 0.42, TT: 0.14 },
    conditions: ["Elevated homocysteine", "Folate deficiency risk", "Neural tube defect risk"],
    recommendations: ["Consider methylfolate (5-MTHF) over folic acid", "Monitor homocysteine levels", "B12 supplementation"],
    references: ["PMID:15060097"]
  },
  "rs1801131": {
    rsid: "rs1801131",
    gene: "MTHFR",
    chromosome: "1",
    position: 11854476,
    categories: ["nutrition", "health"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "T",
    trait: "MTHFR A1298C — Methylation",
    riskDescription: "Reduced MTHFR activity, compounded effect with C677T",
    normalDescription: "Normal MTHFR function at this position",
    heterozygousDescription: "Mildly reduced MTHFR activity",
    populationFrequency: { TT: 0.45, TG: 0.43, GG: 0.12 },
    conditions: ["Reduced methylation capacity", "Homocysteine elevation (with C677T)"],
    recommendations: ["Methylfolate supplementation", "Check compound heterozygosity with C677T"],
    references: ["PMID:10930360"]
  },
  "rs4988235": {
    rsid: "rs4988235",
    gene: "MCM6",
    chromosome: "2",
    position: 136608646,
    categories: ["nutrition"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "A",
    trait: "MCM6/LCT — Lactose Tolerance",
    riskDescription: "Lactase non-persistence: lactose intolerance in adulthood",
    normalDescription: "Lactase persistence: can digest dairy throughout life",
    heterozygousDescription: "Likely lactose tolerant (dominant trait)",
    populationFrequency: { AA: 0.35, AG: 0.42, GG: 0.23 },
    conditions: ["Lactose intolerance", "Dairy maldigestion"],
    recommendations: ["Lactase enzyme supplements with dairy", "Calcium from non-dairy sources", "Fermented dairy may be tolerated"],
    references: ["PMID:11788828"]
  },
  "rs671": {
    rsid: "rs671",
    gene: "ALDH2",
    chromosome: "12",
    position: 112241766,
    categories: ["nutrition", "health"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "ALDH2*2 — Alcohol Flush Reaction",
    riskDescription: "Severely reduced aldehyde dehydrogenase: alcohol flush, acetaldehyde accumulation, esophageal cancer risk",
    normalDescription: "Normal alcohol metabolism",
    heterozygousDescription: "Partial enzyme deficiency: flushing with alcohol, cancer risk if drinking",
    populationFrequency: { GG: 0.72, GA: 0.24, AA: 0.04 },
    conditions: ["Alcohol flush reaction", "Esophageal cancer risk with alcohol", "Acetaldehyde toxicity"],
    recommendations: ["Avoid or strictly limit alcohol", "Never drink through the flush", "No nitroglycerin patches"],
    references: ["PMID:19448012"]
  },
  "rs9939609": {
    rsid: "rs9939609",
    gene: "FTO",
    chromosome: "16",
    position: 53820527,
    categories: ["nutrition", "health"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "T",
    trait: "FTO — Obesity Risk",
    riskDescription: "Increased appetite, higher BMI (average 1.5-3 kg per allele), obesity risk",
    normalDescription: "Average weight regulation at this locus",
    heterozygousDescription: "Moderate obesity risk (1.2x)",
    populationFrequency: { TT: 0.34, TA: 0.46, AA: 0.2 },
    conditions: ["Obesity susceptibility", "Increased appetite", "Type 2 diabetes risk"],
    recommendations: ["Portion control", "High protein diet may counteract FTO effects", "Regular exercise", "Mindful eating"],
    references: ["PMID:17434869"]
  },
  "rs2228570": {
    rsid: "rs2228570",
    gene: "VDR",
    chromosome: "12",
    position: 48272895,
    categories: ["nutrition"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "VDR FokI — Vitamin D Receptor",
    riskDescription: "Less active vitamin D receptor: may need higher vitamin D intake",
    normalDescription: "More active VDR: efficient vitamin D utilization",
    heterozygousDescription: "Intermediate vitamin D receptor activity",
    populationFrequency: { CC: 0.35, CT: 0.48, TT: 0.17 },
    conditions: ["Vitamin D deficiency susceptibility", "Bone health", "Immune function"],
    recommendations: ["Monitor 25(OH)D levels", "Consider higher vitamin D supplementation (2000-4000 IU)", "Sun exposure"],
    references: ["PMID:10632262"]
  },
  "rs1800562": {
    rsid: "rs1800562",
    gene: "HFE",
    chromosome: "6",
    position: 26093141,
    categories: ["nutrition", "health"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "G",
    trait: "HFE C282Y — Hereditary Hemochromatosis",
    riskDescription: "Homozygous: hereditary hemochromatosis with iron overload. Carrier: mild iron elevation",
    normalDescription: "Normal iron regulation",
    heterozygousDescription: "Carrier: mildly increased iron absorption, usually asymptomatic",
    populationFrequency: { GG: 0.87, GA: 0.12, AA: 0.01 },
    conditions: ["Hereditary hemochromatosis", "Iron overload", "Liver disease", "Joint pain"],
    recommendations: ["Regular ferritin and transferrin saturation testing", "Avoid iron supplements unless deficient", "Limit vitamin C with meals (enhances iron absorption)", "Blood donation helps"],
    references: ["PMID:8696333"]
  },
  "rs1799945": {
    rsid: "rs1799945",
    gene: "HFE",
    chromosome: "6",
    position: 26091179,
    categories: ["nutrition", "health"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "C",
    trait: "HFE H63D — Iron Metabolism",
    riskDescription: "Mildly increased iron absorption, risk with compound heterozygosity (C282Y)",
    normalDescription: "Normal iron regulation",
    heterozygousDescription: "Slightly elevated iron levels, usually benign alone",
    populationFrequency: { CC: 0.72, CG: 0.25, GG: 0.03 },
    conditions: ["Mild iron elevation", "Compound hemochromatosis risk"],
    recommendations: ["Check ferritin levels periodically", "Assess C282Y status"],
    references: ["PMID:8696333"]
  },
  "rs4654748": {
    rsid: "rs4654748",
    gene: "NBPF3",
    chromosome: "1",
    position: 17345640,
    categories: ["nutrition"],
    significance: "moderate",
    riskAllele: "T",
    normalAllele: "C",
    trait: "Vitamin B6 Levels",
    riskDescription: "Lower circulating vitamin B6 levels",
    normalDescription: "Normal vitamin B6 levels",
    heterozygousDescription: "Slightly lower B6 levels",
    populationFrequency: { CC: 0.3, CT: 0.48, TT: 0.22 },
    conditions: ["Vitamin B6 deficiency risk"],
    recommendations: ["Consider B6 supplementation", "B6-rich foods (poultry, fish, potatoes)"],
    references: ["PMID:19744961"]
  },
  "rs12934922": {
    rsid: "rs12934922",
    gene: "BCMO1",
    chromosome: "16",
    position: 81264597,
    categories: ["nutrition"],
    significance: "moderate",
    riskAllele: "T",
    normalAllele: "A",
    trait: "BCMO1 — Beta-Carotene Conversion",
    riskDescription: "Reduced ability to convert beta-carotene to vitamin A (~50% reduction when homozygous)",
    normalDescription: "Normal beta-carotene to vitamin A conversion",
    heterozygousDescription: "Moderately reduced conversion (~30% reduction)",
    populationFrequency: { AA: 0.3, AT: 0.48, TT: 0.22 },
    conditions: ["Poor beta-carotene converter", "Vitamin A deficiency risk on vegan diet"],
    recommendations: ["Pre-formed vitamin A (retinol) from animal sources or supplements", "Don't rely solely on beta-carotene for vitamin A"],
    references: ["PMID:19103647"]
  },
  "rs7946": {
    rsid: "rs7946",
    gene: "PEMT",
    chromosome: "17",
    position: 17409572,
    categories: ["nutrition"],
    significance: "moderate",
    riskAllele: "T",
    normalAllele: "C",
    trait: "PEMT — Choline Synthesis",
    riskDescription: "Reduced phosphatidylethanolamine N-methyltransferase: higher dietary choline needs",
    normalDescription: "Normal endogenous choline production",
    heterozygousDescription: "Slightly increased choline requirements",
    populationFrequency: { CC: 0.35, CT: 0.48, TT: 0.17 },
    conditions: ["Choline deficiency susceptibility", "Non-alcoholic fatty liver risk"],
    recommendations: ["Ensure adequate choline intake (eggs, liver, cruciferous vegetables)"],
    references: ["PMID:16702348"]
  },
  "rs602662": {
    rsid: "rs602662",
    gene: "FUT2",
    chromosome: "19",
    position: 49206674,
    categories: ["nutrition"],
    significance: "moderate",
    riskAllele: "A",
    normalAllele: "G",
    trait: "FUT2 — Vitamin B12 Absorption",
    riskDescription: "Non-secretor status: reduced B12 absorption in gut",
    normalDescription: "Secretor status: normal B12 absorption",
    heterozygousDescription: "Intermediate B12 absorption",
    populationFrequency: { GG: 0.45, GA: 0.42, AA: 0.13 },
    conditions: ["Vitamin B12 deficiency risk", "Gut microbiome variation"],
    recommendations: ["Monitor B12 levels", "Consider sublingual B12", "Regular testing if vegan/vegetarian"],
    references: ["PMID:23754956"]
  },
  "rs174547": {
    rsid: "rs174547",
    gene: "FADS1",
    chromosome: "11",
    position: 61597212,
    categories: ["nutrition"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "T",
    trait: "FADS1 — Omega-3/6 Fatty Acid Conversion",
    riskDescription: "Reduced conversion of ALA to EPA/DHA omega-3 fatty acids",
    normalDescription: "Efficient omega-3 fatty acid conversion",
    heterozygousDescription: "Moderately reduced conversion",
    populationFrequency: { TT: 0.34, TC: 0.48, CC: 0.18 },
    conditions: ["Omega-3 deficiency risk", "Inflammatory balance"],
    recommendations: ["Direct EPA/DHA sources (fish oil, fatty fish)", "Don't rely on ALA (flax/chia) alone"],
    references: ["PMID:21829377"]
  },
  "rs1544410": {
    rsid: "rs1544410",
    gene: "VDR",
    chromosome: "12",
    position: 48239835,
    categories: ["nutrition"],
    significance: "moderate",
    riskAllele: "A",
    normalAllele: "G",
    trait: "VDR BsmI — Vitamin D Utilization",
    riskDescription: "Altered vitamin D receptor expression, may need more vitamin D",
    normalDescription: "Normal vitamin D receptor expression",
    heterozygousDescription: "Intermediate VDR expression",
    populationFrequency: { GG: 0.3, GA: 0.48, AA: 0.22 },
    conditions: ["Bone mineral density variation", "Vitamin D requirements"],
    recommendations: ["Check vitamin D levels", "Supplement if low"],
    references: ["PMID:9843978"]
  },
  "rs7041": {
    rsid: "rs7041",
    gene: "GC",
    chromosome: "4",
    position: 72618334,
    categories: ["nutrition"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "T",
    trait: "GC/DBP — Vitamin D Binding Protein",
    riskDescription: "Lower vitamin D binding protein levels, may have lower total 25(OH)D",
    normalDescription: "Normal vitamin D binding and transport",
    heterozygousDescription: "Intermediate vitamin D binding protein levels",
    populationFrequency: { TT: 0.3, TG: 0.48, GG: 0.22 },
    conditions: ["Altered vitamin D bioavailability", "Lower total 25(OH)D levels"],
    recommendations: ["Free 25(OH)D may be more informative", "Adequate supplementation"],
    references: ["PMID:20541252"]
  },
  "rs1260326": {
    rsid: "rs1260326",
    gene: "GCKR",
    chromosome: "2",
    position: 27730940,
    categories: ["nutrition", "health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "GCKR — Glucose/Lipid Metabolism",
    riskDescription: "Higher triglycerides but lower fasting glucose (paradoxical)",
    normalDescription: "Standard glucose-lipid metabolism",
    heterozygousDescription: "Intermediate metabolic effects",
    populationFrequency: { CC: 0.28, CT: 0.49, TT: 0.23 },
    conditions: ["Elevated triglycerides", "Lower fasting glucose", "Metabolic trait"],
    recommendations: ["Monitor triglyceride levels", "Omega-3 for triglyceride management"],
    references: ["PMID:21423719"]
  },
  "rs4588": {
    rsid: "rs4588",
    gene: "GC",
    chromosome: "4",
    position: 72618323,
    categories: ["nutrition"],
    significance: "well-established",
    riskAllele: "A",
    normalAllele: "C",
    trait: "GC — Vitamin D Binding & Transport",
    riskDescription: "Lower DBP concentration, altered vitamin D transport",
    normalDescription: "Normal DBP and vitamin D transport",
    heterozygousDescription: "Intermediate DBP levels",
    populationFrequency: { CC: 0.5, CA: 0.4, AA: 0.1 },
    conditions: ["Vitamin D transport variation"],
    recommendations: ["Consider bio-available vitamin D testing"],
    references: ["PMID:20541252"]
  },
  // ============================================================
  // TRAITS (~30 SNPs)
  // ============================================================
  "rs12913832": {
    rsid: "rs12913832",
    gene: "HERC2/OCA2",
    chromosome: "15",
    position: 28365618,
    categories: ["traits"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "A",
    trait: "HERC2/OCA2 — Eye Color",
    riskDescription: "GG: very high probability of blue eyes",
    normalDescription: "AA: brown eyes most likely",
    heterozygousDescription: "AG: likely green/hazel eyes, possibly blue",
    populationFrequency: { AA: 0.36, AG: 0.4, GG: 0.24 },
    conditions: ["Eye color determination"],
    recommendations: ["UV protection for light eyes (more sensitive to sunlight)"],
    references: ["PMID:18172690"]
  },
  "rs1805007": {
    rsid: "rs1805007",
    gene: "MC1R",
    chromosome: "16",
    position: 89986117,
    categories: ["traits", "health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "MC1R R151C — Red Hair & Skin Sensitivity",
    riskDescription: "Strong red hair predictor, fair skin, increased melanoma risk, pain sensitivity",
    normalDescription: "Normal melanin production",
    heterozygousDescription: "Carrier: may have reddish tint, freckling, increased sun sensitivity",
    populationFrequency: { CC: 0.87, CT: 0.12, TT: 0.01 },
    conditions: ["Red hair", "Fair skin", "Melanoma susceptibility", "Altered pain/anesthesia sensitivity"],
    recommendations: ["Rigorous sun protection (SPF 50+)", "Regular skin cancer screening", "Inform anesthesiologist (may need more anesthesia)"],
    references: ["PMID:11260224"]
  },
  "rs1815739": {
    rsid: "rs1815739",
    gene: "ACTN3",
    chromosome: "11",
    position: 66560624,
    categories: ["traits"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "ACTN3 R577X — Muscle Fiber Type",
    riskDescription: "XX genotype: no alpha-actinin-3, endurance advantage, less sprint power",
    normalDescription: "RR genotype: full alpha-actinin-3, sprint/power advantage",
    heterozygousDescription: "RX: intermediate — good at both power and endurance",
    populationFrequency: { CC: 0.3, CT: 0.52, TT: 0.18 },
    conditions: ["Athletic performance type", "Muscle fiber composition"],
    recommendations: ["Tailor training to genotype (endurance vs power)", "XX: focus on endurance sports", "RR: explosive/power training may be optimal"],
    references: ["PMID:12879365"]
  },
  "rs2304672": {
    rsid: "rs2304672",
    gene: "PER2",
    chromosome: "2",
    position: 239153925,
    categories: ["traits"],
    significance: "moderate",
    riskAllele: "G",
    normalAllele: "C",
    trait: "PER2 — Circadian Rhythm / Sleep",
    riskDescription: "Altered circadian rhythm, tendency toward being a morning person (advanced sleep phase)",
    normalDescription: "Standard circadian rhythm timing",
    heterozygousDescription: "Mildly shifted circadian preference",
    populationFrequency: { CC: 0.82, CG: 0.17, GG: 0.01 },
    conditions: ["Advanced sleep phase", "Morning chronotype"],
    recommendations: ["Align schedule with chronotype", "Light exposure management"],
    references: ["PMID:11232563"]
  },
  "rs713598": {
    rsid: "rs713598",
    gene: "TAS2R38",
    chromosome: "7",
    position: 141672604,
    categories: ["traits", "nutrition"],
    significance: "well-established",
    riskAllele: "G",
    normalAllele: "C",
    trait: "TAS2R38 — Bitter Taste Perception",
    riskDescription: "Reduced bitter taste sensitivity (non-taster): may consume more cruciferous vegetables",
    normalDescription: "Strong bitter taste sensitivity (supertaster): may avoid bitter foods",
    heterozygousDescription: "Medium taster: moderate bitter perception",
    populationFrequency: { CC: 0.2, CG: 0.49, GG: 0.31 },
    conditions: ["Bitter taste perception", "Food preferences", "Vegetable consumption patterns"],
    recommendations: ["Supertasters: try preparing bitter vegetables with fat/salt to mask bitterness", "Non-tasters: ensure adequate vegetable intake isn't compromised"],
    references: ["PMID:12595690"]
  },
  "rs53576": {
    rsid: "rs53576",
    gene: "OXTR",
    chromosome: "3",
    position: 8804371,
    categories: ["traits"],
    significance: "moderate",
    riskAllele: "A",
    normalAllele: "G",
    trait: "OXTR — Oxytocin Receptor / Empathy",
    riskDescription: "Reduced oxytocin receptor expression: may affect social bonding and empathy",
    normalDescription: "Higher oxytocin receptor expression: stronger empathy and social sensitivity",
    heterozygousDescription: "Intermediate social-emotional sensitivity",
    populationFrequency: { GG: 0.4, GA: 0.44, AA: 0.16 },
    conditions: ["Social cognition variation", "Empathy differences", "Stress response"],
    recommendations: ["Social connection is important regardless of genotype", "Mindfulness and compassion practices"],
    references: ["PMID:19934046"]
  },
  "rs4950": {
    rsid: "rs4950",
    gene: "MSRA",
    chromosome: "8",
    position: 10081204,
    categories: ["traits"],
    significance: "moderate",
    riskAllele: "G",
    normalAllele: "A",
    trait: "Leadership Tendency",
    riskDescription: "Associated with leadership role occupancy in GWAS studies",
    normalDescription: "Average leadership tendency at this locus",
    heterozygousDescription: "Intermediate association",
    populationFrequency: { AA: 0.4, AG: 0.44, GG: 0.16 },
    conditions: ["Leadership behavior"],
    recommendations: ["Environmental factors are much more important than genetics for leadership"],
    references: ["PMID:23213369"]
  },
  "rs1800955": {
    rsid: "rs1800955",
    gene: "DRD4",
    chromosome: "11",
    position: 637315,
    categories: ["traits"],
    significance: "moderate",
    riskAllele: "C",
    normalAllele: "T",
    trait: "DRD4 — Novelty Seeking",
    riskDescription: "Higher dopamine D4 receptor expression, associated with novelty seeking",
    normalDescription: "Standard D4 receptor levels",
    heterozygousDescription: "Intermediate novelty seeking tendency",
    populationFrequency: { TT: 0.3, TC: 0.48, CC: 0.22 },
    conditions: ["Novelty seeking behavior", "ADHD association"],
    recommendations: ["Channel novelty seeking productively", "Varied activities and experiences"],
    references: ["PMID:8900340"]
  },
  "rs1800544": {
    rsid: "rs1800544",
    gene: "ADRA2A",
    chromosome: "10",
    position: 112836655,
    categories: ["traits"],
    significance: "moderate",
    riskAllele: "G",
    normalAllele: "C",
    trait: "ADRA2A — Attention & Focus",
    riskDescription: "Altered adrenergic receptor function, associated with attention variation",
    normalDescription: "Normal adrenergic attention regulation",
    heterozygousDescription: "Intermediate attention regulation",
    populationFrequency: { CC: 0.35, CG: 0.47, GG: 0.18 },
    conditions: ["Attention regulation", "Working memory"],
    recommendations: ["Regular breaks during focused work", "Exercise improves attention"],
    references: ["PMID:10903899"]
  },
  "rs1800588": {
    rsid: "rs1800588",
    gene: "LIPC",
    chromosome: "15",
    position: 58723675,
    categories: ["traits", "health"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "LIPC — HDL Cholesterol Levels",
    riskDescription: "Lower hepatic lipase activity, generally higher HDL cholesterol",
    normalDescription: "Normal hepatic lipase activity",
    heterozygousDescription: "Intermediate HDL levels",
    populationFrequency: { CC: 0.5, CT: 0.4, TT: 0.1 },
    conditions: ["HDL cholesterol variation"],
    recommendations: ["Regular lipid panel testing", "Heart-healthy lifestyle"],
    references: ["PMID:10391209"]
  },
  "rs4570625": {
    rsid: "rs4570625",
    gene: "TPH2",
    chromosome: "12",
    position: 72332381,
    categories: ["traits"],
    significance: "moderate",
    riskAllele: "T",
    normalAllele: "G",
    trait: "TPH2 — Serotonin Synthesis",
    riskDescription: "Altered tryptophan hydroxylase-2 activity affecting brain serotonin synthesis",
    normalDescription: "Normal brain serotonin synthesis",
    heterozygousDescription: "Mildly altered serotonin synthesis",
    populationFrequency: { GG: 0.6, GT: 0.34, TT: 0.06 },
    conditions: ["Mood regulation", "Anxiety susceptibility", "Emotional reactivity"],
    recommendations: ["Adequate tryptophan intake", "Regular exercise (boosts serotonin)", "Sunlight exposure"],
    references: ["PMID:15866551"]
  },
  "rs6311": {
    rsid: "rs6311",
    gene: "HTR2A",
    chromosome: "13",
    position: 47471478,
    categories: ["traits"],
    significance: "moderate",
    riskAllele: "A",
    normalAllele: "G",
    trait: "HTR2A — Serotonin 2A Receptor",
    riskDescription: "Altered serotonin 2A receptor expression",
    normalDescription: "Normal 5-HT2A receptor density",
    heterozygousDescription: "Intermediate receptor expression",
    populationFrequency: { GG: 0.3, GA: 0.48, AA: 0.22 },
    conditions: ["SSRI response variation", "Sleep quality", "Mood regulation"],
    recommendations: ["Discuss SSRI response with prescriber", "Good sleep hygiene"],
    references: ["PMID:11958969"]
  },
  "rs1805009": {
    rsid: "rs1805009",
    gene: "MC1R",
    chromosome: "16",
    position: 89986546,
    categories: ["traits"],
    significance: "well-established",
    riskAllele: "C",
    normalAllele: "G",
    trait: "MC1R D294H — Red Hair & Fair Skin",
    riskDescription: "Strong red hair and fair skin variant, melanoma risk",
    normalDescription: "Normal pigmentation",
    heterozygousDescription: "Carrier: possible fair skin traits",
    populationFrequency: { GG: 0.96, GC: 0.04, CC: 1e-3 },
    conditions: ["Red hair", "UV sensitivity", "Melanoma risk"],
    recommendations: ["Sun protection", "Regular dermatology check-ups"],
    references: ["PMID:11260224"]
  },
  "rs1805008": {
    rsid: "rs1805008",
    gene: "MC1R",
    chromosome: "16",
    position: 89986154,
    categories: ["traits"],
    significance: "well-established",
    riskAllele: "T",
    normalAllele: "C",
    trait: "MC1R R160W — Red Hair Variant",
    riskDescription: "Red hair and fair skin predisposition",
    normalDescription: "Normal MC1R function",
    heterozygousDescription: "Carrier of red hair variant",
    populationFrequency: { CC: 0.9, CT: 0.09, TT: 0.01 },
    conditions: ["Red/auburn hair", "Fair skin", "Sun sensitivity"],
    recommendations: ["Rigorous sun protection"],
    references: ["PMID:11260224"]
  },
  // ============================================================
  // CARRIER STATUS (~20 SNPs)
  // ============================================================
  "rs75527207": {
    rsid: "rs75527207",
    gene: "CFTR",
    chromosome: "7",
    position: 117559590,
    categories: ["carrier"],
    significance: "pathogenic",
    riskAllele: "A",
    normalAllele: "G",
    trait: "CFTR ΔF508 — Cystic Fibrosis",
    riskDescription: "Most common CF mutation. Homozygous: cystic fibrosis. Carrier: unaffected",
    normalDescription: "No ΔF508 mutation detected",
    heterozygousDescription: "CF carrier: 1 in 25 Caucasians. Relevant for family planning",
    populationFrequency: { GG: 0.96, GA: 0.039, AA: 1e-3 },
    conditions: ["Cystic fibrosis (homozygous)", "CF carrier status"],
    recommendations: ["Genetic counseling if carrier", "Partner carrier testing recommended", "Family planning discussion"],
    references: ["PMID:2475911"]
  },
  "rs334": {
    rsid: "rs334",
    gene: "HBB",
    chromosome: "11",
    position: 5227002,
    categories: ["carrier", "health"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "A",
    trait: "HBB — Sickle Cell Trait",
    riskDescription: "HbS mutation. Homozygous: sickle cell disease. Carrier: sickle cell trait (malaria resistance)",
    normalDescription: "Normal hemoglobin",
    heterozygousDescription: "Sickle cell trait: generally asymptomatic, malaria resistance, rare exercise complications",
    populationFrequency: { AA: 0.92, AT: 0.07, TT: 0.01 },
    conditions: ["Sickle cell disease (homozygous)", "Sickle cell trait (carrier)", "Malaria resistance (carrier)"],
    recommendations: ["Genetic counseling", "Carrier partner testing", "Hydration during intense exercise", "Altitude awareness"],
    references: ["PMID:2288582"]
  },
  "rs80338939": {
    rsid: "rs80338939",
    gene: "GJB2",
    chromosome: "13",
    position: 20763612,
    categories: ["carrier"],
    significance: "pathogenic",
    riskAllele: "A",
    normalAllele: "G",
    trait: "GJB2 35delG — Hearing Loss",
    riskDescription: "Most common cause of autosomal recessive non-syndromic hearing loss",
    normalDescription: "Normal connexin-26 function",
    heterozygousDescription: "Carrier: normal hearing, family planning relevance",
    populationFrequency: { GG: 0.96, GA: 0.038, AA: 2e-3 },
    conditions: ["Non-syndromic hearing loss (homozygous)", "DFNB1 carrier"],
    recommendations: ["Genetic counseling for carriers", "Partner testing", "Newborn hearing screening awareness"],
    references: ["PMID:9771706"]
  },
  "rs28937594": {
    rsid: "rs28937594",
    gene: "HEXA",
    chromosome: "15",
    position: 72638892,
    categories: ["carrier"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "HEXA — Tay-Sachs Disease",
    riskDescription: "Carrier of Tay-Sachs disease mutation",
    normalDescription: "Normal hexosaminidase A activity",
    heterozygousDescription: "Carrier: unaffected, family planning relevance",
    populationFrequency: { CC: 0.97, CT: 0.03, TT: 3e-4 },
    conditions: ["Tay-Sachs disease (homozygous)", "Carrier status"],
    recommendations: ["Genetic counseling", "Partner carrier screening", "Common in Ashkenazi Jewish population"],
    references: ["PMID:8401469"]
  },
  "rs76151636": {
    rsid: "rs76151636",
    gene: "SMN1",
    chromosome: "5",
    position: 70247773,
    categories: ["carrier"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "SMN1 — Spinal Muscular Atrophy",
    riskDescription: "SMA carrier: 1 in 40-60 people carry a deletion/mutation",
    normalDescription: "Normal SMN1 function",
    heterozygousDescription: "SMA carrier: relevant for family planning",
    populationFrequency: { CC: 0.975, CT: 0.024, TT: 1e-3 },
    conditions: ["Spinal muscular atrophy (homozygous)", "SMA carrier"],
    recommendations: ["Genetic counseling", "Partner screening", "SMA newborn screening available"],
    references: ["PMID:7677801"]
  },
  "rs11970772": {
    rsid: "rs11970772",
    gene: "PAH",
    chromosome: "12",
    position: 103234207,
    categories: ["carrier"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "PAH — Phenylketonuria (PKU)",
    riskDescription: "PKU carrier: phenylalanine hydroxylase deficiency",
    normalDescription: "Normal phenylalanine metabolism",
    heterozygousDescription: "Carrier: unaffected, slightly elevated phenylalanine",
    populationFrequency: { CC: 0.98, CT: 0.02, TT: 1e-4 },
    conditions: ["Phenylketonuria (homozygous)", "PKU carrier"],
    recommendations: ["Genetic counseling", "Partner testing", "All newborns screened at birth"],
    references: ["PMID:25087612"]
  },
  "rs113993960": {
    rsid: "rs113993960",
    gene: "CFTR",
    chromosome: "7",
    position: 117559592,
    categories: ["carrier"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "CFTR — Cystic Fibrosis (F508del proxy)",
    riskDescription: "CF-associated variant",
    normalDescription: "Normal CFTR function",
    heterozygousDescription: "Potential CF carrier",
    populationFrequency: { CC: 0.96, CT: 0.038, TT: 2e-3 },
    conditions: ["Cystic fibrosis"],
    recommendations: ["Genetic counseling", "Sweat chloride test if symptomatic"],
    references: ["PMID:2475911"]
  },
  "rs1800553": {
    rsid: "rs1800553",
    gene: "GJB2",
    chromosome: "13",
    position: 20763485,
    categories: ["carrier"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "GJB2 167delT — Hearing Loss",
    riskDescription: "Carrier of common hearing loss mutation (Ashkenazi Jewish population)",
    normalDescription: "Normal GJB2/connexin-26",
    heterozygousDescription: "Carrier: normal hearing",
    populationFrequency: { CC: 0.97, CT: 0.03, TT: 3e-4 },
    conditions: ["Non-syndromic hearing loss"],
    recommendations: ["Genetic counseling for carriers", "Partner testing"],
    references: ["PMID:9771706"]
  },
  "rs1800548": {
    rsid: "rs1800548",
    gene: "SERPINA1",
    chromosome: "14",
    position: 94847262,
    categories: ["carrier", "health"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "SERPINA1 — Alpha-1 Antitrypsin Deficiency",
    riskDescription: "Z allele carrier: risk of lung and liver disease, especially with smoking",
    normalDescription: "Normal alpha-1 antitrypsin levels",
    heterozygousDescription: "MZ carrier: mildly reduced AAT, increased risk if smoking",
    populationFrequency: { CC: 0.95, CT: 0.048, TT: 2e-3 },
    conditions: ["Alpha-1 antitrypsin deficiency", "COPD", "Liver cirrhosis"],
    recommendations: ["Never smoke", "AAT level testing", "Avoid occupational dust/fume exposure"],
    references: ["PMID:12576314"]
  },
  "rs74315329": {
    rsid: "rs74315329",
    gene: "MUTYH",
    chromosome: "1",
    position: 45798475,
    categories: ["carrier", "health"],
    significance: "pathogenic",
    riskAllele: "T",
    normalAllele: "C",
    trait: "MUTYH Y179C — Colorectal Cancer",
    riskDescription: "Biallelic MUTYH mutations: MUTYH-associated polyposis (MAP), high colorectal cancer risk",
    normalDescription: "Normal MUTYH DNA repair",
    heterozygousDescription: "Carrier: mildly increased colorectal cancer risk (~1.5x)",
    populationFrequency: { CC: 0.98, CT: 0.019, TT: 1e-3 },
    conditions: ["MUTYH-associated polyposis", "Colorectal cancer risk"],
    recommendations: ["Enhanced colorectal screening", "Colonoscopy starting at 25-30 if biallelic"],
    references: ["PMID:12606733"]
  }
};
function lookupSnp(rsid) {
  return snpDatabase[rsid] || null;
}
function searchSnps(query) {
  const q = query.toLowerCase();
  return Object.values(snpDatabase).filter(
    (s) => s.rsid.toLowerCase().includes(q) || s.gene.toLowerCase().includes(q) || s.trait.toLowerCase().includes(q)
  );
}
function getCategories() {
  const cats = /* @__PURE__ */ new Set();
  Object.values(snpDatabase).forEach((s) => s.categories.forEach((c) => cats.add(c)));
  return [...cats];
}
function getAllSnps() {
  return Object.values(snpDatabase);
}
function matchSnps(userSnps) {
  const results = [];
  for (const [rsid, snpInfo] of Object.entries(snpDatabase)) {
    const userGenotype = userSnps.get(rsid);
    if (userGenotype) {
      const genotype = userGenotype.genotype || userGenotype.allele1 + userGenotype.allele2;
      const riskLevel = assessRisk(snpInfo, genotype);
      results.push({
        ...snpInfo,
        userGenotype: genotype,
        userAllele1: userGenotype.allele1,
        userAllele2: userGenotype.allele2,
        riskLevel,
        riskPercent: riskLevel === "high" ? 85 : riskLevel === "moderate" ? 55 : riskLevel === "low" ? 20 : 10
      });
    }
  }
  return results;
}
function assessRisk(snp, genotype) {
  const alleles = genotype.split("");
  const riskCount = alleles.filter((a) => a === snp.riskAllele).length;
  if (riskCount === 2) return "high";
  if (riskCount === 1) return "moderate";
  return "low";
}
export {
  getAllSnps as a,
  getCategories as g,
  lookupSnp as l,
  matchSnps as m,
  searchSnps as s
};
